Banking stem cells for research and clinical applications

Progress in Brain Research

Volumn 200, Issue , 2012, Pages 41-58

  Stacey, Glyn ^a  

^a NATIONAL INSTITUTE FOR BIOLOGICAL STANDARDS AND CONTROL   (United Kingdom)

Author keywords

Cell banking; Quality; Safety; Standardization; Stem cell lines; Validation

Indexed keywords

ARTICLE; BACTERIUM CONTAMINATION; CELL COUNT; CELL CULTURE; CELL EXPANSION; CELL POPULATION; CELL VIABILITY; CYTOMEGALOVIRUS INFECTION; EMBRYONIC STEM CELL; EPSTEIN BARR VIRUS INFECTION; FUNGAL CONTAMINATION; GENETIC STABILITY; GENETIC VARIABILITY; GOOD MANUFACTURING PRACTICE; HUMAN; PLURIPOTENT STEM CELL; PRESERVATION; PRIORITY JOURNAL; QUALITY CONTROL; RISK ASSESSMENT; STANDARDIZATION; STEM CELL; STEM CELL BANKING; VIRAL CONTAMINATION;

EID: 84870260918     PISSN: 00796123     EISSN: 18757855     Source Type: Book Series    
DOI: 10.1016/B978-0-444-59575-1.00003-X     Document Type: Chapter

References (40)

1. Adewumi O., Aflatoonian B., Ahrlund-Richter L., Amit M., Andrews P.W., Beighton G., Bello P.A., Benvenisty N., Berry L.S., Bevan S., Blum B., Brooking J., Chen K.G., Choo A.B., Churchill G.A., Corbel M., Damjanov I., Draper J.S., Dvorak P., Emanuelsson K., Fleck R.A., Ford A., Gertow K., Gertsenstein M., Gokhale P.J., Hamilton R.S., Hampl A., Healy L.E., Hovatta O., Hyllner J., Imreh M.P., Itskovitz-Eldor J., Jackson J., Johnson J.L., Jones M., Kee K., King B.L., Knowles B.B., Lako M., Lebrin F., Mallon B.S., Manning D., Mayshar Y., McKay R.D., Michalska A.E., Mikkola M., Mileikovsky M., Minger S.L., Moore H.D., Mummery C.L., Nagy A., Nakatsuji N., O'Brien C.M., Oh S.K., Olsson C., Otonkoski T., Park K.Y., Passier R., Patel H., Patel M., Pedersen R., Pera M.F., Piekarczyk M.S., Pera R.A., Reubinoff B.E., Robins A.J., Rossant J., Rugg-Gunn P., Schulz T.C., Semb H., Sherrer E.S., Siemen H., Stacey G.N., Stojkovic M., Suemori H., Szatkiewicz J., Turetsky T., Tuuri T., van den Brink S., Vintersten K., Vuoristo S., Ward D., Weaver T.A., Young L.A., Zhang W. Characterization of human embryonic stem cell lines by the International Stem Cell Initiative. Nat. Biotechnol. 2007, 25:803-816.
2. Amps K., Andrews P.W., Anyfantis G., Armstrong L., Avery S., Baharvand H., Baker J., Baker D., Munoz M.B., Beil S., Benvenisty N., Ben-Yosef D., Biancotti J.C., Bosman A., Brena R.M., Brison D., Caisander G., Camarasa M.V., Chen J., Chiao E., Choi Y.M., Choo A.B., Collins D., Colman A., Crook J.M., Daley G.Q., Dalton A., De Sousa P.A., Denning C., Downie J., Dvorak P., Montgomery K.D., Feki A., Ford A., Fox V., Fraga A.M., Frumkin T., Ge L., Gokhale P.J., Golan-Lev T., Gourabi H., Gropp M., Lu G., Hampl A., Harron K., Healy L., Herath W., Holm F., Hovatta O., Hyllner J., Inamdar M.S., Irwanto A.K., Ishii T., Jaconi M., Jin Y., Kimber S., Kiselev S., Knowles B.B., Kopper O., Kukharenko V., Kuliev A., Lagarkova M.A., Laird P.W., Lako M., Laslett A.L., Lavon N., Lee D.R., Lee J.E., Li C., Lim L.S., Ludwig T.E., Ma Y., Maltby E., Mateizel I., Mayshar Y., Mileikovsky M., Minger S.L., Miyazaki T., Moon S.Y., Moore H., Mummery C., Nagy A., Nakatsuji N., Narwani K., Oh S.K., Oh S.K., Olson C., Otonkoski T., Pan F., Park I.H., Pells S., Pera M.F., Pereira L.V., Qi O., Raj G.S., Reubinoff B., Robins A., Robson P., Rossant J., Salekdeh G.H., Schulz T.C., Sermon K., Sheik Mohamed J., Shen H., Sherrer E., Sidhu K., Sivarajah S., Skottman H., Spits C., Stacey G.N., Strehl R., Strelchenko N., Suemori H., Sun B., Suuronen R., Takahashi K., Tuuri T., Venu P., Verlinsky Y., Ward-van Oostwaard D., Weisenberger D.J., Wu Y., Yamanaka S., Young L., Zhou Q. Screening ethnically diverse human embryonic stem cells identifies a chromosome 20 minimal amplicon conferring growth advantage. Nat. Biotechnol. 2011, 29:1132-1144.
3. Andrews P.W., Arias-Diaz J., Auerbach J., Alvarez M., Ahrlund-Richter L., Baker D., Benvenisty N., Ben-Josef D., Blin G., Borghese L., Borstlap J., Bruce K., Brüstle O., Buckle R., Camby C., Choo A.B., Chen W., Collins D., Colman A., Crombie C., Crook J.M., Cypess R., De Sousa P., Dhawan J., Douay L., Dvorak P., Dyke T., Eriksson L., Firpo M., Fitzgerald C., Glover C., Gokhale P., Greene M., Ha H.-Y., Hampl A., Healy L., Hei D., Holm F., Hovatta O., Hunt C., Hwang S.-M., Inamdar M., Isasi R., Itskovitz-Eldor J., Jessie N., Kim D.-W., Kirzner R., Kiatpongsan S., Knowles B.B., Kuo H.-C., Laughlin M., Lavon N., Ludwig T., Lakov M., Lee D.-R., Macauley J., McKay R., Menasche P., Menendez P.-M., Michalska A., Mileikovskaia M., Minger S., Mishra G., Moody J., Montgomery K., Morris C., Mummery C., Nagy A., Nakamura Y., Nakatsuji N., Nishikawa S.-I., Oh S., Oh S.-K., Olson P., Otonkoski T.M., Patole M., Park H.-S., Pei X., Pera M., Rajala K., Reubinoff B., Robins A., Rooke H., Rumayor V., Scotmann H., Sherlock J., Simon C., Sipp D., Skinner R., Smith D., Stacey G.N., Stefanovic S., Strehl R., Taft R., Takahashi T., Talib S., Terstegge S., Turner R., Tuuri T., Yu J., Zandstra P., Zapata A., Zeng F., Zhou Q., Tannenbaum S. Consensus guidance for banking and supply of human embryonic stem cell lines for research purposes. Stem Cell Rev. Rep. 2009, 5:301-314.
4. Baker D.E., Harrison N.J., Maltby E., Smith K., Moore H.D., Shaw P.J., Heath P.R., Holden H., Andrews P.W. Adaptation to culture of human embryonic stem cells and oncogenesis in vivo. Nat. Biotechnol. 2007, 25:207-215.
5. Barallon R., Bauer S.R., Butler J., Capes-Davis A., Dirks W.G., Elmore E., Furtado M., Kline M.C., Kohara A., Los G.V., MacLeod R.A., Masters J.R., Nardone M., Nims R.M., Price R.W., Reid Y., Shewale P.J., Sykes Y.A., Steuer J., Storts G., Thomson A.F., Taraporewala D.R., Alston-Roberts Z., Kerrigan C. Recommendation of short tandem repeat profiling for authenticating human cell lines, stem cells, and tissues. In Vitro Cell. Dev. Biol. Anim. 2010, 46(9):727-732.
6. Coecke S., Balls M., Bowe G., Davis J., Gstraunthaler G., Hartung T., Hay R., Merten O.-W., Price A., Shechtman L., Stacey G.N., Stokes W. Guidance on good cell culture practice. A report of the second ECVAM task force on good cell culture practice. Altern. Lab. Anim. 2005, 33:1-27.
7. Crook J.M., Hei D., Stacey G. The International Stem Cell Banking Initiative (ISCBI): raising standards to bank on. In Vitro Cell. Dev. Biol. Anim. 2010, 46(3-4):169-172.
8. Day J.D., Stacey G.N. Long term ex-situ conservation of biological resources and the role of biological resource centres. Methods in Molecular Biology 2007, vol. 368:1-15. Humana Press, Totowa. second ed. J.G. Day, G.N. Stacey (Eds.).
9. GMP E.U. European Directive 2003/94 laying down the principles and guidelines of good manufacturing practice in respect of medicinal products for human use and investigational medicinal products for human use. Official Journal of the European Commission 2003, L242/22 8 October 2003.
10. Directive E.U. On setting standards of quality and safety for the donation, procurement, testing, processing, preservation, storage and distribution of human tissues and cells /23/EC. http://europa.eu.int/eurlex/pri/en/oj/dat/2004/l_102/l_10220040407en00480058.pdf.
11. European Pharmacopeia European Pharmacopeia Section 2.6.7 (Mycoplasma) (6th Edition), Supplement 6.1 2007, Maisonneuve SA, Sainte Ruffine, pp. 3317-3322.
12. European Pharmacopeia European Pharmacopeia Section 2.6.1 (Sterility) (6th Edition), Supplement 8 2007, Maisonneuve SA, Sainte Ruffine, pp. 5795-5797. http://www.pheur.org.
13. European Pharmacopeia European Pharmacopeia General Chapter 2.7.29: Nucleated Cell Count and Viability 2008, (01/2008:20729).
14. FDA GMP Title 21, code of federal regulations, part 210: 114Q1 7 Current good manufacturing practice in manufacturing, processing, 1142 packaging or holding of drugs; general 2004, US FDA, April 1st 2004.
15. Gartler S.M. Genetic markers as tracers in cell culture. Natl. Cancer Inst. Monogr. 1961, 26:167-195.
16. Grandela C., Wolvetang E. hESC adaptation, selection and stability. Stem Cell Rev. 2007, 3(3):183-191.
17. HTA The Human Tissue (Quality and Safety for Human Application) Regulations 2007. Statutory Instrument 2007, 2007(1523). http://www.legislation.gov.uk/uksi/2007/1523/regulation/5/made.
18. Inamdar M.S., Healy L., Sinha A., Stacey G. Global solutions to the challenges of setting up and managing a stem cell laboratory. Stem Cell Rev. Rep 2012, 8:830-843. http://www.ncbi.nlm.nih.gov/pubmed/22038333.
19. International Stem Cell Banking Initiative website. http://www.stemcellforum.org/forum_initiatives/international_stem_cell_banking_initiative.cfm.
20. Josephson R., Sykes G., Liu Y., Ording C., Xu W., Zeng X., Shin S., Loring J., Maitra A., Rao M.S., Auerbach J.M. A molecular scheme for improved characterization of human embryonic stem cell lines. BMC Biol. 2006, 4:28.
21. Laurent L.C., Ulitsky I., Slavin I., Tran H., Schork A., Morey R., Lynch C., Harness J.V., Lee S., Barrero M.J., Ku S., Martynova M., Semechkin R., Galat V., Gottesfeld J., Izpisua Belmonte J.C., Murry C., Keirstead H.S., Park H.S., Schmidt U., Laslett A.L., Muller F.J., Nievergelt C.M., Shamir R., Loring J.F. Dynamic changes in the copy number of pluripotency and cell proliferation genes in human ESCs and iPSCs during reprogramming and time in culture. Cell Stem Cell 2011, 8:106-118.
22. MacLeod R.A.F., Dirks W.G., Matsuo Y., Kaufman M., Milch H., Drexler H.G. Widespread intra-species cross-contamination of human tumour cell lines arising at source. Int. J. Cancer 1999, 83:555-563.
23. Masters J.R., Thomson J.A., Daly-Burns B., Reid Y.A., Dirks W.G., Packer P., Toji L.H., Ohno T., Tanabe H., Arlett C.F., Kelland L.R., Harrison M., Virmani A., Ward T.H., Ayres K.L., Debenham P.G. Short tandem repeat profiling provides an international reference standard for human cell lines. Proc. Natl. Acad. Sci. USA 2001, 98:8012-8017.
24. National Institutes of Health Notice Regarding Authentication of Cultured Cell LinesNotice No 2007, NOT-OD-08-017 (2007). http://grants.nih.gov/grants/guide/notice-files/NOT-OD-08-017.html/.
25. Nelson-Rees W.A., Daniels D.W., Flandermeryer R.R. Cross-contamination of cells in culture. Science 1981, 212:416-452.
26. Okita K., Ichisaka T., Yamanaka S. Generation of germline-competent induced pluripotent stem cells. Nature 2007, 448(7151):313-317.
27. Rottem S. Interaction of mycoplasmas with host cells. Physiol. Rev. 2003, 83(2):417-432.
28. Rottem S., Naot Y. Subversion and exploitation of host cells by mycoplasmas. Trends Microbiol. 1998, 6(11):436-440.
29. Sathananthan A.H., Trounson A. Human embryonic stem cells and their spontaneous differentiation. Ital. J. Anat. Embryol. 2005, 110(2 Suppl. 1):151-157.
30. Stacey G.N. Risk assessment of cell culture procedures. Medicines from Animal Cells 2007, 569-588. Wiley, Chichester. G.N. Stacey, J. Davis (Eds.).
31. Stacey G.N. Quality control of human stem cell lines. Human Cell Culture Volume 2007, vol. VI:255-276. Springer, Dordrecht. J.R. Masters, B.O. Palsson, J.A. Thomson (Eds.).
32. Stacey G.N. Cell culture contamination. Cancer Cell Culture: Methods and Protocols 2010, 79-91. Springer Science+Business Media LLC, New York. I.A. Cree (Ed.).
33. Stacey G.N., Auerbach J.M. Quality control of stem cell lines. Culture of Stem Cells 2007, 1-21. John Wiley & Sons, Hoboken. I.R. Freshney, G.N. Stacey, J.M. Auerbach (Eds.).
34. Stacey G.N., Davis J. Medicines from Animal Cells 2007, Wiley, Chichester.
35. Stacey G.N., Doyle A., Tyrrell D. Source materials. Safety in Cell and Tissue Culture 1998, 1-25. Kluwer Academic Publishers, Dordrecht. G.N. Stacey, A. Doyle, P. Hambleton (Eds.).
36. Stacey G.N., Masters J.R., Hay R.J., Drexler H.G., MacCleod R.A.F., Freshney I.R. Cell contamination leads to inaccurate data. We must take action now. Nature 2000, 403:356.
37. Thomson J., Itskovitz-Eldor J., Shapiro S.S., Waknitz M.A., Swiergiel J.J., Marshall V.S., Jones J.M. Embryonic stem cell lines derived from human blastocysts. Science 1998, 282:1145-1147.
38. UK Road Map for Stem Cell Therapy and for step by step guidance see the respective E-Toolkit at. http://www.sc-toolkit.ac.uk/regulatoryroutes/projectview.
39. Watt S.M., Austin E., Armitage S. Cryopreservation of haematopoietic stem/progenitor cells for therapeutic use. Methods in Molecular Biology 2007, 368:237-259. Humana Press, Totowa. second ed. J.G. Day, G.N. Stacey (Eds.).
40. WHO Recommendations for the Evaluation of Animal Cell Cultures as Substrates for the Manufacture of Biological Medicinal Products and for the Characterization of Cell Banks 2010, WHO, Geneva. http://www.who.int/biologicals/expert_committee/en/.